Eric K. Rowinsky, Chief Medical Officer at STEMLINE THERAPEUTICS INC (STML), sold 1,640 shares at $13.99 ($23K) on 2015-02-18, disclosed to the SEC on 2015-02-20.
Open-market sale of $23k STML by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FBIO | BUY | 2023-02-14 | $10K | — | Filing → |
| FBIO | SELL | 2021-04-09 | $127K | — | Filing → |
| STML | SELL | 2015-04-28 | $171K | — | Filing → |